0001209191-22-018225.txt : 20220311 0001209191-22-018225.hdr.sgml : 20220311 20220311171830 ACCESSION NUMBER: 0001209191-22-018225 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220119 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Curran Terrie CENTRAL INDEX KEY: 0001690298 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39094 FILM NUMBER: 22734093 MAIL ADDRESS: STREET 1: C/O MYOVANT SCIENCES INC. STREET 2: 320 WEST 37TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001783183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824151574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (877) 742-8466 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-01-19 2022-01-21 0 0001783183 Phathom Pharmaceuticals, Inc. PHAT 0001690298 Curran Terrie C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 1 1 0 0 President and Chief Executive Common Stock 42955 D Common Stock 724.1 I by 401(k) On January 21, 2022, the Reporting Person filed a Form 4 (the "Original Form 4") which inadvertently reported incorrect amounts of securities beneficially owned following the transactions reported. Following the transactions reported in the Original Form 4, the Reporting Person (i) directly owns 42,955 shares of Common Stock, which includes 41,250 restricted stock units, and (ii) indirectly owns 724.10 shares of Common Stock through a 401(k) account. /s/ Larry Miller, Attorney-in-Fact for Terrie Curran 2022-03-11